Cementos Bio Bio Cash Flow Statement

Financials in millions CLP. Fiscal year is January - December.

Millions CLP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	33,088	32,427	22,797	10,560	26,879
Depreciation & Amortization	33,691	30,505	26,869	26,581	23,439
Other Amortization	120.54	134.94	193.93	183.58	161.43
Asset Writedown & Restructuring Costs	287.57	508.61	584.07	2,550	991.27
Other Operating Activities	-7,170	2,882	-8,214	-16,691	-25,634
Operating Cash Flow	60,017	66,459	42,230	23,183	25,836
Operating Cash Flow Growth	-9.69%	57.37%	82.16%	-10.27%	-23.03%
Capital Expenditures	-13,344	-12,123	-18,144	-13,808	-21,976
Sale of Property, Plant & Equipment	6.56	1,504	917.43	361.43	27,337
Divestitures	-	-	-	80	-
Sale (Purchase) of Intangibles	-	-164.71	-182.8	-516.55	-78.51
Other Investing Activities	-1,000	-	-	-	-
Investing Cash Flow	-14,338	-10,783	-17,410	-13,883	5,282
Short-Term Debt Issued	1,184	8,306	6,976	18,809	4,853
Long-Term Debt Issued	3,750	-	-	-	-
Total Debt Issued	4,934	8,306	6,976	18,809	4,853
Long-Term Debt Repaid	-33,123	-25,234	-21,465	-33,280	-13,259
Net Debt Issued (Repaid)	-28,189	-16,928	-14,489	-14,471	-8,405
Common Dividends Paid	-138.7	-27,082	-6,640	-24,974	-22,110
Financing Cash Flow	-28,328	-44,010	-21,129	-39,445	-30,515
Foreign Exchange Rate Adjustments	-169.14	640.88	-746.07	-363.34	62.5
Net Cash Flow	17,182	12,307	2,946	-30,509	665.62
Free Cash Flow	46,673	54,336	24,086	9,374	3,860
Free Cash Flow Growth	-14.10%	125.59%	156.93%	142.83%	-84.06%
Free Cash Flow Margin	12.60%	15.11%	6.90%	2.81%	1.33%
Free Cash Flow Per Share	176.64	205.65	91.16	35.48	14.61
Cash Interest Paid	9,055	11,393	14,925	8,193	3,677
Cash Income Tax Paid	2,194	11,854	8,038	-1,146	4,874
Levered Free Cash Flow	40,799	42,802	15,534	8,739	-9,254
Unlevered Free Cash Flow	46,413	49,494	24,505	15,702	-7,028

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.